LIPUS can promote osteogenesis of hPDLCs and inhibit the periodontal inflammatory response via TLR5
Oral Diseases · 2024
DOI: 10.1111/odi.14807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Ping Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Stomatology and Central Lab, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nan…. Hauptthemen laut MEDLINE: Periodontal Ligament, Osteogenesis, Toll-Like Receptor 5. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Research on Application of Medical Innovation (SKYD2022129), Science and Technology Project of Ke Jiao Xing Wei (KJXW2021039), Suzhou Science and Technology Development Project (SYS2020177, SYSD2020245).
Abstract (Originalsprache)
In this study, we isolated human periodontal ligament cells (hPDLCs) to find the optimal time of LIPUS stimulation and to explore how LIPUS affects inflammatory and osteogenic responses in hPDLCs in an inflammatory environment. The target molecules of LIPUS were identified by high‐throughput sequencing. RT–qPCR and WB were used to detect how LIPUS affected the expression of related genes in TNFα‐induced inflammation. The expression of ROS and inflammatory factors was detected by flow cytometry. Immunohistochemistry was used to further verify gene expression in rats. hPDLCs were isolated successfully. The optimal LIPUS stimulation condition was 45 mW/cm 2 for 30 min and continued for 3 days, and this intensity significantly promoted the osteogenesis and mineralization of hPDLCs. LIPUS significantly inhibited the upregulation of IL‐6 and ROS, increased the percentage of cells in the G2 phase, inhibited cell apoptosis, and inhibited the upregulation of TLR5 expression in an inflammatory environment. LIPUS can effectively restrain the inflammation and oxidative stress response of hPDLCs and promote osteogenesis in an inflammatory environment. LIPUS inhibited the periodontal inflammatory response through TLR5 in hPDLCs and dental pulp.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Stomatology and Central Lab, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.
- Department of Stomatology, The Dushu Lake Hospital Affiliated to Soochow University, Suzhou, Jiangsu, China.
ORCID-Profile: Ping Li
Förderung
- Research on Application of Medical Innovation (SKYD2022129)
- Science and Technology Project of Ke Jiao Xing Wei (KJXW2021039)
- Suzhou Science and Technology Development Project (SYS2020177, SYSD2020245)
- The fifth Gusu Outstanding Youth Medical Foundation of Suzhou, Jiangsu Province, China (No.GSWS2019062, GSWS2020077)
Zitieren
APA
Li, P., Zhang, Z., Liu, J., & Xue, H. (2024). LIPUS can promote osteogenesis of hPDLCs and inhibit the periodontal inflammatory response via TLR5. Oral Diseases. https://doi.org/10.1111/odi.14807
Vancouver
Li P, Zhang Z, Liu J, Xue H. LIPUS can promote osteogenesis of hPDLCs and inhibit the periodontal inflammatory response via TLR5. Oral Diseases. 2024. doi:10.1111/odi.14807
BibTeX
@article{Li2024,
author = {Li, Ping and Zhang, Zhipeng and Liu, Jingjing and Xue, Hui},
title = {LIPUS can promote osteogenesis of hPDLCs and inhibit the periodontal inflammatory response via TLR5},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14807}
}
EUVIMED